Bellevue Group Ag Bio N Tech Se Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Bio N Tech Se stock. As of the latest transaction made, Bellevue Group Ag holds 8,721 shares of BNTX stock, worth $869,658. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,721

Holding current value

$869,658

% of portfolio

0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$78.36 - $124.66 $683,377 - $1.09 Million	8,721 New	8,721 $1.04 Million
Q1 2023 May 15, 2023	SELL	$122.57 - $153.67 $3.02 Million - $3.78 Million	-24,600 Reduced 11.13%	196,480 $24.5 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $7.99 Million - $12.6 Million	67,500 Added 43.95%	221,080 $33.2 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $303,807 - $435,801	2,380 Added 1.57%	153,580 $20.7 Million
Q2 2022 Aug 11, 2022	BUY	$123.25 - $186.24 $4.86 Million - $7.34 Million	39,434 Added 35.28%	151,200 $22.5 Million
Q1 2022 May 13, 2022	SELL	$126.25 - $231.85 $214,625 - $394,145	-1,700 Reduced 1.5%	111,766 $19.1 Million
Q4 2021 Feb 10, 2022	BUY	$216.64 - $362.52 $21.8 Million - $36.5 Million	100,766 Added 793.43%	113,466 $29.3 Million
Q3 2021 Nov 12, 2021	SELL	$205.93 - $447.23 $2.04 Million - $4.43 Million	-9,900 Reduced 43.81%	12,700 $3.47 Million
Q2 2021 Aug 12, 2021	SELL	$113.32 - $241.49 $2.6 Million - $5.53 Million	-22,900 Reduced 50.33%	22,600 $5.06 Million
Q1 2021 May 12, 2021	BUY	$85.73 - $119.5 $2.36 Million - $3.29 Million	27,500 Added 152.78%	45,500 $4.97 Million
Q4 2020 Feb 16, 2021	SELL	$72.71 - $129.54 $2.29 Million - $4.08 Million	-31,500 Reduced 63.64%	18,000 $1.47 Million
Q3 2020 Nov 16, 2020	SELL	$57.81 - $104.17 $28,905 - $52,085	-500 Reduced 1.0%	49,500 $3.43 Million
Q2 2020 Aug 13, 2020	BUY	$38.58 - $66.74 $1.93 Million - $3.34 Million	50,000 New	50,000 $3.34 Million

Others Institutions Holding BNTX

# of Institutions

358

Shares Held

38.4M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account